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 Patient: Female, 45
 Final Diagnosis: Leptospirosis
 Symptoms: Back pain • fever • headache • Hemopthysis • nausea • sepsis
 Medication: —
 Clinical Procedure: —
 Specialty: Infectious Diseases
 Objective: Rare disease
 Background: Leptospirosis is a zoonosis transmitted through urine of infected animals. Symptoms range from mild influ-
enza-like symptoms to severe pulmonary hemorrhagic syndrome (SPHS); the latter are often fatal. The sero-
group distribution in Denmark has changed from 1988 to 2012, with Icterohaemorrhagiae and Sejroe now be-
ing predominant.
 Case report: A 45-year-old Danish woman living in an area endemic for Hanta virus, without prior medical history, was ad-
mitted because of lower back pain radiating to the left hip, fever, headache, nausea, and malaise. Two weeks 
before admission she had been bitten by a mouse or a rat. Blood tests revealed raised white cells and CRP, 
electrolyte imbalances, raised creatinine, low thrombocytes, and a slightly decreased clotting factor (II, VII, and 
X). Treatment with broad-spectrum intravenous antibiotics and supporting therapy was initiated very quickly. 
Eight hours after admission she died from respiratory failure where severe hemoptysis was observed.
  Leptospiral DNA was later detected in a urine sample.
 Conclusions: This case represents leptospirosis with severe pulmonary hemorrhagic syndrome. In spite of immediate treat-
ment with broad-spectrum antibiotics, the patient died a few hours after hospital admission.
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Background
Leptospirosis is a zoonosis caused by spirochetes maintained 
in the renal tubules of certain animals, such as cattle and rats. 
Transmission occurs primarily through direct or indirect contact 
with urine from infected animals. Symptoms range from mild 
influenza-like illness, Weil’s syndrome (jaundice, renal failure, 
hemorrhage, and myocarditis with arrhythmias) to pulmonary 
hemorrhage with respiratory failure [1].
Pulmonary involvement in leptospirosis was first described 
in 1943 [2,3]. In recent years, severe pulmonary hemorrhag-
ic syndrome (SPHS) caused by leptospirosis has gained in-
creased attention due to the 1995 outbreak in Nicaragua and 
the emergence of leptospirosis-associated SPHS in Brazil from 
2003 to 2005 [4,5].
In Denmark, a non-endemic area, leptospirosis had an average 
annual incidence rate of 0.34/100,000 inhabitants from 1980 to 
2012, with 4 being fatal. In the same period, serogroup distribu-
tion changed, with Icterohaemorrhagiae and Sejroe becoming 
predominant [6]. Serovars of the Icterohaemorrhagiae serogroup 
are associated with more severe forms of leptospirosis [7,8].
SPHS has a mortality rate of over 50% and death may occur in 
less than 72 hours after onset of symptoms [2,8].
To the best of our knowledge, a case of leptospirosis debuting 
with severe back pain and terminating with severe pulmonary 
involvement has not been reported in Denmark. Herein, we 
describe a case of leptospirosis-associated SPHS.
Case Report
A 45-year-old Danish woman without prior medical history 
was admitted because of lower back pain radiating to the left 
hip, fever, headache, nausea, and malaise. The woman lived 
in an area endemic for Hanta virus.
Two weeks before admission, she was bitten by a mouse or a rat, 
and 2 days before admission she contacted the doctor on call, 
complaining of severe back pain. She was referred to the outpa-
tient clinic, where the suspicion of a Hantavirus infection or sepsis 
without known focus was raised, and she was then hospitalized.
Initially, temperature was 39.7°C, blood pressure was 
104/77 mmHg, peripheral saturation was 96%, and heart 
rate was 132 beats/min.
A healed, non-infected scratch mark was found on her left 
thigh. Physical examination was otherwise normal and jaun-
dice was not found.
Blood tests revealed white blood cells 11.4×109/L, C-reactive 
protein 288 mg/L, thrombocytes 59×109/L, hemoglobin 7.2 
mmol/L, creatinine 127 μmol/L, and erythrocyte sedimen-
tation rate 51 mm. Liver function test results were normal. 
Kidney function tests revealed creatinine 127 mmol/L, urea 
11.3 mmol/L, potassium 2.9 mmol/L, and sodium 126 mmol/L. 
Blood cultures, urine cultures, tests for specific Hanta IgG and 
IgM, and influenza throat swab were negative. Immunoglobulins 
and plasma protein were normal.
Liver function tests showed a slight increase in alanine trans-
aminase (ALT) 48 U/L, gamma-glutamyl transpeptidase (GGT), 
while bilirubin and alkaline phosphatase were normal. Clotting 
factors II, VII, and X were 0.69 arbitrary units per liter. Other 
laboratory markers consistent with disseminated intravascular 
coagulation were not taken before she died (Table 1).
A chest X-ray showed diffuse alveolar infiltrates in the basal 2/3 
of both lungs (Figure 1). Renal ultrasound was normal. Urine 
dipstick analysis showed traces of protein, blood, and leuco-
cytes. ECG showed sinus tachycardia of 109 beats per minute.
Intravenous treatment with piperacillin-tazobactam 4+0.5 g 3 
times daily and ciprofloxacin 400 mg 2 times daily was initi-
ated because of sepsis. Intravenous isotonic sodium chloride 
and glucose with high flow was given to correct hypotension 
and electrolyte imbalances. Later, she was treated with 1 L of 
Ringer-acetate.
Eight hours after admission, peripheral oxygen saturation 
dropped to 80% despite oxygen flow 4 L. per minute. Her re-
spiratory rate increased to 44 per minute. Severe hemoptysis 
was observed and she was given 3 L of erythrocyte concen-
trate and 450 grams of fresh frozen plasma. Shortly thereaf-
ter, she went into cardiac arrest and died, although advanced 
life support was initiated.
Leptospiral DNA was later detected in a urine sample by PCR 
analysis. Microscopic agglutination test (MAT) performed on 
serum, however, was non-reactive for all 15 serovars tested.
Discussion
Due to the course of the disease, a medico-legal autopsy was 
performed. Therefore, the autopsy report is not available to 
us. We strongly believe, however, that this case represents an 
example of leptospirosis-associated SPHS.
The patient history with a rat bite, clinical manifestations with 
respiratory failure and hemoptysis, and paraclinical investi-
gations with diffuse alveolar infiltrations, renal failure, and 
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positive urine leptospiral DNA strongly suggest leptospirosis-
associated SPHS as the cause of this fatal course of the disease.
Only 4 deaths due to leptospirosis were reported in Denmark 
from 1980 to 2012 [6].
In Denmark, it is mandatory to report cases of leptospirosis to 
the State Serum Institute of Denmark to map the incidence of 
the disease. This will help map the serogroup distribution over 
time, which will help determine if the Icterohaemorrhagiae se-
rogroup is still becoming more predominant.
Conclusions
Leptospirosis is a very rare disease in Denmark, and SPHS is a dif-
ferential diagnosis not often considered. With back pain and fever 
as initial symptoms in a patient living in an area endemic for Hanta 
virus, leptospirosis is not the first diagnosis that comes to mind.
Studies have indicated that high-dose intravenous steroids such 
as methylprednisolone and dexamethasone improve the out-
come of pulmonary leptospirosis, and in some cases, it might 
be life-saving [2,9,10].
In conclusion, leptospirosis is a disease that needs to be rec-
ognized by doctors, as it is a potentially severe or fatal infec-
tion. The diagnosis has to be suspected when a patient has 
been in contact with rodents or been where rats might live. 
Intravenous steroids should be considered for patients with 
confirmed leptospirosis. Furthermore, the use of gloves and 
other forms of protection is important when working in a po-
tentially contaminated environment.
Although rare in Denmark, leptospirosis has to be suspected 
when anamnestic or clinical signs of the disease are present in 
a patient. This will probably result in faster initiation of treat-
ment of the disease and its potential complications.
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Analysis Units
Normal 
range
Patient 
result 
Hemoglobin, B mmol/L 7.3–9.5 7.2
Leucocytes, B 10E9/L 3.50–8.80 11.4
Sedimentation rate mm 2–30 51
Thrombocytes, B 10E9/L 165–400 59
Neutrophils, B 10E9/L 1.50–7.50 10.8
Lymphocytes, B 10E9/L 1.00–4.00 0.25
Monocytes, B 10E9/L 0.20–0.80 0.34
Basophils, B 10E9/L <0.20 0.02
Eosinophils, B 10E9/L <0.50 0.02
Albumin, P g/L 36–48 36
Calcium ion mmol/L 1.18–1.32 1.03
Potassium, P mmol/L 3.5–4.4 2.9
Urea, P mmol/L 2.6–6.4 11.3
Creatinine, P µmol/L 45–90 127
eGFR mL/min >59 44
Sodium, P mmol/L 137–145 126
Clotting factor 
(II, VII, X)
arbitrary units 
per liter
0.70–1.30 0.69
ALAT U/L 10–45 48
ALP U/L 35–105 70
Bilirubin µmol/L 5–25 12
GGT U/L 10–75 38
CRP mg/L <6 288
Immunoglobulin A g/L 0.70–4.30 1.17
Immunoglobulin G g/L 6.1–15.7 7.7
Immunoglobulin M g/L 0.4–2.30 0.69
Protein, P g/L 64–79 66
Table 1. Biochemical results upon hospital admission.
Figure 1.  X-ray of thorax shows diffuse alveolar infiltrates in 
basal 2/3 of both lungs.
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